ICMR says Covaxin effective in neutralising UK strain, double mutant variant | Latest News India - Hindustan Times
close_game
close_game

ICMR says Covaxin effective in neutralising UK strain, double mutant variant

By | Written by Shankhyaneel Sarkar | Edited by Avik Roy, Hindustan Times, New Delhi
Apr 21, 2021 02:18 PM IST

In its study the ICMR also pointed out that the vaccine made by the Hyderabad-based pharmaceutical company is also effective against other variants like the Brazil variant as well the double mutant variant that has been detected in India.

The Indian Council of Medical Research (ICMR) on Wednesday said that Bharat Biotech’s Covaxin is effective in neutralising the multiple variants of SARS-Cov-2 as well as the double mutant strain that has been found in India.

Vials of Covaxin, a Covid-19 vaccine seen at Thane Civil hospital, in Thane, Mumbai. (Praful Gangurde / HT Photo)
Vials of Covaxin, a Covid-19 vaccine seen at Thane Civil hospital, in Thane, Mumbai. (Praful Gangurde / HT Photo)

“ICMR study shows Covaxin neutralises against multiple variants of SARS-CoV-2 and effectively neutralises the double mutant strain as well,” the ICMR said in a tweet.

Unlock exclusive access to the latest news on India's general elections, only on the HT App. Download Now! Download Now!

The study, which was published in the Journal for Travel Medicine in March, highlights that Covaxin is effective against the UK variants as well as other strains of Covid-19. “It was reassuring from the PRNT50 data generated in our laboratory that the indigenous BBV152/ COVAXIN, following its roll out in vaccination program, could be expected to work against the new UK-variant,” the study said.

In its study the ICMR also pointed out that the vaccine made by the Hyderabad-based pharmaceutical company is also effective against other variants like the Brazil variant as well the double mutant variant that has been detected in India.

ICMR further said that it has successfully cultured and isolated several variants of SARS-Cov-2. It said that it has isolated and cultured the following variants of SARS-Cov-2 -- B.1.617 (double mutant variant identified in certain regions of India and several other countries), B.1.1.7 (UK variant), B.1.1.28 (Brazil variant) and B.1.351 (Southern African variant).

Covaxin along with Covishield and Sputnik V have been approved by the Centre for vaccinating individuals against the coronavirus disease (Covid-19). Covaxin and Covishield were the first two vaccines which received approval in January and have been used widely in India’s vaccination drive which began on January 16.

Tell us what your First Vote will stand for in a short video & get a chance to be featured on HT’s social media handles. Click here to know more!

Get Current Updates on India News, Elections 2024, Lok Sabha Election 2024 Live, Election 2024 Date, Weather Today along with Latest News and Top Headlines from India and around the world.
SHARE THIS ARTICLE ON
Share this article
SHARE
Story Saved
Live Score
OPEN APP
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Friday, May 24, 2024
Start 14 Days Free Trial Subscribe Now
Follow Us On